|
|
Article: Moldova Pharmaceuticals and Healthcare Report Q2 2009.
- Article from:
- M2 Presswire
- Article date:
- April 30, 2009
CopyrightCOPYRIGHT 2009 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-30 April 2009-www.companiesandmarkets.com: Moldova Pharmaceuticals and Healthcare Report Q2 2009(C)1994-2009 M2 COMMUNICATIONS LTD
RDATE:30042009
-www.companiesandmarkets.com adds new report: Moldova Pharmaceuticals and Healthcare Report Q2 2009
Moldova's pharmaceutical market stood at US$206mn in 2008 and is forecast to grow to US$309mn in 2013. This represents a compound annual growth rate (CAGR) of 14.08%. The country has seen its healthcare budget almost triple since the introduction of obligatory health insurance in 2003, and in the coming years, growth in the drug market will be driven by the continuing modernization of the ...